美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Roivant Sciences Ltd.

27.17

-0.5000-1.81%

成交量：418.94萬

成交額：1.16億

市值：194.46億

市盈率：-23.15

高：27.94

開：27.50

低：27.01

收：27.67

52周最高：27.94

52周最低：8.73

股本：7.16億

流通股本：4.67億

量比：0.62

換手率：0.90%

股息：- -

股息率：- -

每股收益(TTM):-1.1734

每股收益(LYR):-0.2371

淨資產收益率：-19.14%

總資產收益率：-14.47%

市淨率：4.55

市盈率(LYR):-114.60

資料載入中...

總覽公司新聞資訊公告

異動解讀 | 旗下藥物二期研究顯示積極成果，Roivant Sciences盤中大漲5.02%

異動解讀 | 候選藥物二期數據積極疊加財報亮眼，Roivant Sciences盤中大漲19.68%

Roivant股價盤前飆升15.8%，實驗性藥物對罕見皮膚病顯效及三季度業績提振市場信心

異動解讀 | 候選藥物二期數據積極疊加財報亮眼，Roivant Sciences盤前大漲9.93%

Roivant公布Brepocitinib治療皮膚結節病的二期積極數據同步披露2025財年第三季度業績

Priovant計劃與FDA溝通後推進關鍵項目，三期臨牀試驗擬於2026年啓動

Pulmovant宣佈完成Mosliciguat治療間質性肺病相關肺動脈高壓二期Phocus研究患者入組

財報前瞻｜Roivant Sciences Ltd.本季度營收或下滑，機構觀點偏謹慎

2026年最有價值的管線資產排名

Roivant Sciences將於2026年2月6日公布2025財年第三季度業績並舉行業務更新會

Ro 與安進公司合作，研究肥胖症護理和 GLP-1 獲取的障礙

Jefferies：Roivant(ROIV.US)2026年迎三大催化劑，目標價看高至 24 美元

Roivant強調持續的管線進展及公司下一階段增長的展望——2025投資者日

Roivant Sciences：Lnp訴訟持續推進，法院於2025年9月在Pfizer/BioNTech案件中作出有利的Markman裁決

Roivant將在11月10日（星期一）發布2025年9月30日結束的第二季度財務業績及業務更新

拉馬斯瓦米支持的 Strive 公司將以 13 億美元收購塞姆勒公司，全股票交易，增加比特幣持有量

美股異動｜生物製藥公司Roivant升逾13%，Brepocitinib三期試驗數據表現積極

老虎资讯综合

Roivant Sciences Ltd.和Priovant宣佈Brepocitinib治療皮肌炎的3期Valor研究在52周安慰劑對照試驗中獲得積極結果

Roivant Sciences Ltd.盤中異動臨近收盤急速拉升5.01%

Pulmovant旗下藥物Mosliciguat獲得日本孤兒藥認定，用於治療間質性肺病相關肺動脈高壓

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ROIV/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ROIV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ROIV\",,,,,undefined,":{"symbol":"ROIV","market":"US","secType":"STK","nameCN":"Roivant Sciences Ltd.","latestPrice":27.17,"timestamp":1770747801383,"preClose":27.67,"halted":0,"volume":4189359,"delay":0,"changeRate":-0.018070112034694615,"floatShares":467000000,"shares":715701137,"eps":-1.173433,"marketStatus":"交易中","change":-0.5,"latestTime":"02-10 13:23:22 EST","open":27.5,"high":27.94,"low":27.01,"amount":115523120.29847099,"amplitude":0.03361,"askPrice":27.17,"askSize":297,"bidPrice":27.16,"bidSize":426,"shortable":3,"etf":0,"ttmEps":-1.173433,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1770757200000},"marketStatusCode":2,"adr":0,"listingDate":1607403600000,"exchange":"NASDAQ","adjPreClose":27.67,"preHourTrading":{"tag":"盘前","latestPrice":27.5,"preClose":27.67,"latestTime":"09:29 EST","volume":8980,"amount":248795.39,"timestamp":1770733799095,"change":-0.17,"changeRate":-0.006144,"amplitude":0.042645},"postHourTrading":{"tag":"盘后","latestPrice":27.7666,"preClose":27.67,"latestTime":"19:51 EST","volume":466907,"amount":12920654.0717,"timestamp":1770684703866,"change":0.0966,"changeRate":0.003491,"amplitude":0.020239},"volumeRatio":0.622668,"impliedVol":0.5321,"impliedVolPercentile":0.9482},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ROIV\",,,,,undefined,":{"symbol":"ROIV","floatShares":467000000,"roa":"-14.47%","roe":"-19.14%","lyrEps":-0.237085,"volumeRatio":0.622668,"shares":715701137,"dividePrice":0,"high":27.94,"amplitude":0.03361,"preClose":27.67,"low":27.01,"week52Low":8.73,"pbRate":"4.55","psRate":"1460.98","week52High":27.94,"institutionHeld":0,"latestPrice":27.17,"committee":0.178423,"eps":-1.173433,"divideRate":0,"volume":4189359,"delay":0,"ttmEps":-1.173433,"open":27.5,"prevYearClose":21.7,"prevWeekClose":25.82,"prevMonthClose":21.62,"prevQuarterClose":21.7,"fiveDayClose":21.97,"twentyDayClose":22.16,"sixtyDayClose":21.32},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ROIV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-06","symbol":"ROIV","fiscalQuarterEnding":"2025/12","expectedEps":-0.38,"name":null,"time":"盤前","type":"earning","dateTimestamp":1770354000000,"reportTimeType":"pre","actualEps":-0.2},{"market":"US","date":"2025-11-10","symbol":"ROIV","fiscalQuarterEnding":"2025/09","expectedEps":-0.34,"name":null,"time":"盤前","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-0.4},{"market":"US","date":"2025-08-11","symbol":"ROIV","fiscalQuarterEnding":"2025/06","expectedEps":-0.31,"name":null,"time":"盤前","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-0.3},{"market":"US","date":"2025-05-29","symbol":"ROIV","fiscalQuarterEnding":"2025/03","expectedEps":-0.23,"name":null,"time":"盤前","type":"earning","dateTimestamp":1748491200000,"reportTimeType":"pre","actualEps":-0.31},{"market":"US","date":"2025-02-10","symbol":"ROIV","fiscalQuarterEnding":"2024/12","expectedEps":-0.3,"name":null,"time":"盤前","type":"earning","dateTimestamp":1739163600000,"reportTimeType":"pre","actualEps":-0.2}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ROIV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ROIV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4167,"buy":0.5,"hold":0.0833,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":12,"updateTime":1756962000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ROIV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ROIV","date":"2026-02-09","current":-23.559078,"percent":0.200197,"low":-71.097356,"twenty":-23.053332,"median":-4.886887,"eighty":1.722262,"high":2.128992,"avg":-13.021901,"sd":19.648039,"marketCap":18479403357},"quantilePoints":[{"date":"2021-10-01","current":-7.393592,"twenty":-7.393592,"median":-7.393592,"eighty":-7.393592,"marketCap":6566796009},{"date":"2021-10-08","current":-5.068762,"twenty":-7.200647,"median":-5.392973,"eighty":-5.011828,"marketCap":4501942504},{"date":"2021-10-15","current":-4.760366,"twenty":-6.226432,"median":-5.064808,"eighty":-4.897958,"marketCap":4228033366},{"date":"2021-10-22","current":-5.377158,"twenty":-5.411951,"median":-4.997594,"eighty":-4.833116,"marketCap":4775851643},{"date":"2021-10-29","current":-6.278622,"twenty":-6.291275,"median":-5.22296,"eighty":-4.848931,"marketCap":5576509124},{"date":"2021-11-05","current":-6.120471,"twenty":-6.278622,"median":-5.416696,"eighty":-4.897958,"marketCap":5436042899},{"date":"2021-11-12","current":-6.642371,"twenty":-6.291275,"median":-5.970226,"eighty":-4.945404,"marketCap":5899581441},{"date":"2021-11-19","current":-5.294334,"twenty":-6.278622,"median":-5.426692,"eighty":-4.965964,"marketCap":5618648992},{"date":"2021-11-26","current":-4.632542,"twenty":-6.278622,"median":-5.392973,"eighty":-4.942241,"marketCap":4916317868},{"date":"2021-12-03","current":-5.94289,"twenty":-6.246992,"median":-5.404834,"eighty":-4.886887,"marketCap":6306933493},{"date":"2021-12-10","current":-5.9098,"twenty":-6.278622,"median":-5.56694,"eighty":-4.942241,"marketCap":6271816937},{"date":"2021-12-17","current":-7.24662,"twenty":-6.278622,"median":-5.70859,"eighty":-4.958056,"marketCap":7690525807},{"date":"2021-12-23","current":-7.915029,"twenty":-6.461382,"median":-5.896565,"eighty":-4.962362,"marketCap":8399880243},{"date":"2021-12-31","current":-6.670861,"twenty":-6.679397,"median":-5.936272,"eighty":-4.990763,"marketCap":7079497729},{"date":"2022-01-07","current":-5.658319,"twenty":-6.654395,"median":-5.93348,"eighty":-5.048202,"marketCap":6004931110},{"date":"2022-01-14","current":-5.261244,"twenty":-6.643953,"median":-5.883329,"eighty":-5.051959,"marketCap":5583532435},{"date":"2022-01-21","current":-4.79799,"twenty":-6.611816,"median":-5.850239,"eighty":-4.961285,"marketCap":5091900649},{"date":"2022-01-28","current":-4.420769,"twenty":-6.571592,"median":-5.612629,"eighty":-4.867909,"marketCap":4691571908},{"date":"2022-02-04","current":-4.718575,"twenty":-6.480662,"median":-5.4664,"eighty":-4.79799,"marketCap":5007620914},{"date":"2022-02-11","current":-4.533273,"twenty":-6.411262,"median":-5.421694,"eighty":-4.75404,"marketCap":4810968199},{"date":"2022-02-18","current":-4.229896,"twenty":-6.336473,"median":-5.386985,"eighty":-4.697398,"marketCap":4588438579},{"date":"2022-02-25","current":-4.197996,"twenty":-6.294119,"median":-5.373749,"eighty":-4.638618,"marketCap":4553834970},{"date":"2022-03-04","current":-3.611042,"twenty":-6.287633,"median":-5.300952,"eighty":-4.614157,"marketCap":3917128561},{"date":"2022-03-11","current":-3.209106,"twenty":-6.278622,"median":-5.214919,"eighty":-4.599453,"marketCap":3481123085},{"date":"2022-03-18","current":-3.311185,"twenty":-6.26597,"median":-5.064808,"eighty":-4.551803,"marketCap":3591854634},{"date":"2022-03-25","current":-3.177207,"twenty":-6.224851,"median":-4.997594,"eighty":-4.245208,"marketCap":3446519476},{"date":"2022-04-01","current":-3.087888,"twenty":-6.188476,"median":-4.960747,"eighty":-4.132921,"marketCap":3349629370},{"date":"2022-04-08","current":-2.647672,"twenty":-6.180568,"median":-4.886887,"eighty":-3.804992,"marketCap":2872099563},{"date":"2022-04-14","current":-2.580683,"twenty":-6.166298,"median":-4.831534,"eighty":-3.511515,"marketCap":2799431984},{"date":"2022-04-22","current":-2.494554,"twenty":-6.126648,"median":-4.804608,"eighty":-3.330325,"marketCap":2706002239},{"date":"2022-04-29","current":-2.354195,"twenty":-6.120471,"median":-4.79799,"eighty":-3.283114,"marketCap":2553746358},{"date":"2022-05-06","current":-2.309536,"twenty":-6.09833,"median":-4.74149,"eighty":-3.183587,"marketCap":2505301306},{"date":"2022-05-13","current":-2.207457,"twenty":-5.999036,"median":-4.718575,"eighty":-3.099372,"marketCap":2394569756},{"date":"2022-05-20","current":-2.360575,"twenty":-5.953479,"median":-4.649087,"eighty":-2.763787,"marketCap":2560667080},{"date":"2022-05-27","current":-2.577493,"twenty":-5.941566,"median":-4.632542,"eighty":-2.637464,"marketCap":2795971623},{"date":"2022-06-03","current":-2.781651,"twenty":-5.936272,"median":-4.625924,"eighty":-2.634912,"marketCap":3017434722},{"date":"2022-06-10","current":-2.469034,"twenty":-5.930689,"median":-4.602882,"eighty":-2.583873,"marketCap":2678319352},{"date":"2022-06-17","current":-2.794411,"twenty":-5.9098,"median":-4.599453,"eighty":-2.577493,"marketCap":3031276165},{"date":"2022-06-24","current":-3.055988,"twenty":-5.888623,"median":-4.592835,"eighty":-2.577493,"marketCap":3315025761},{"date":"2022-07-01","current":-3.664409,"twenty":-5.883329,"median":-4.477021,"eighty":-2.580045,"marketCap":3097385357},{"date":"2022-07-08","current":-4.01261,"twenty":-5.863475,"median":-4.327927,"eighty":-2.582597,"marketCap":3391707043},{"date":"2022-07-15","current":-3.540051,"twenty":-5.794648,"median":-4.223516,"eighty":-2.595357,"marketCap":2992270469},{"date":"2022-07-22","current":-3.564922,"twenty":-5.698027,"median":-4.143766,"eighty":-2.610669,"marketCap":3013293447},{"date":"2022-07-29","current":-3.311167,"twenty":-5.603492,"median":-4.012978,"eighty":-2.627256,"marketCap":2798803556},{"date":"2022-08-05","current":-3.136457,"twenty":-5.546323,"median":-3.998124,"eighty":-2.642568,"marketCap":2651127991},{"date":"2022-08-12","current":-3.635628,"twenty":-5.492872,"median":-3.896543,"eighty":-2.647672,"marketCap":3073058176},{"date":"2022-08-19","current":-2.37779,"twenty":-5.442575,"median":-3.739024,"eighty":-2.627256,"marketCap":2603414024},{"date":"2022-08-26","current":-2.409923,"twenty":-5.426692,"median":-3.722442,"eighty":-2.582597,"marketCap":2638595295},{"date":"2022-09-02","current":-2.262114,"twenty":-5.420694,"median":-3.686206,"eighty":-2.571113,"marketCap":2476761450},{"date":"2022-09-09","current":-2.319952,"twenty":-5.407207,"median":-3.656118,"eighty":-2.54405,"marketCap":2540087737},{"date":"2022-09-16","current":-2.0886,"twenty":-5.390578,"median":-3.622956,"eighty":-2.522626,"marketCap":2286782589},{"date":"2022-09-23","current":-1.923582,"twenty":-5.383054,"median":-3.581602,"eighty":-2.479242,"marketCap":2106106321},{"date":"2022-09-30","current":-2.071549,"twenty":-5.375794,"median":-3.540051,"eighty":-2.458826,"marketCap":2268114499},{"date":"2022-10-07","current":-2.830689,"twenty":-5.36316,"median":-3.496169,"eighty":-2.456274,"marketCap":3099286894},{"date":"2022-10-14","current":-2.946489,"twenty":-5.331394,"median":-3.460918,"eighty":-2.458826,"marketCap":3226075903},{"date":"2022-10-21","current":-2.856422,"twenty":-5.302276,"median":-3.442407,"eighty":-2.462654,"marketCap":3127462229},{"date":"2022-10-28","current":-3.377526,"twenty":-5.281098,"median":-3.377526,"eighty":-2.464697,"marketCap":3698012771},{"date":"2022-11-04","current":-3.538361,"twenty":-5.242714,"median":-3.39361,"eighty":-2.46827,"marketCap":3874108617},{"date":"2022-11-11","current":-3.413882,"twenty":-5.212272,"median":-3.409693,"eighty":-2.479242,"marketCap":3737818266},{"date":"2022-11-18","current":-3.079035,"twenty":-5.152485,"median":-3.375884,"eighty":-2.494554,"marketCap":3627093935},{"date":"2022-11-25","current":-3.177564,"twenty":-5.06718,"median":-3.35355,"eighty":-2.494554,"marketCap":3743160940},{"date":"2022-12-02","current":-3.879584,"twenty":-5.051959,"median":-3.352764,"eighty":-2.499658,"marketCap":4570138358},{"date":"2022-12-09","current":-4.310649,"twenty":-5.012624,"median":-3.375884,"eighty":-2.52135,"marketCap":5077931509},{"date":"2022-12-16","current":-4.507707,"twenty":-4.994734,"median":-3.411571,"eighty":-2.52773,"marketCap":5310065520},{"date":"2022-12-23","current":-4.316807,"twenty":-4.979321,"median":-3.429759,"eighty":-2.532833,"marketCap":5085185696},{"date":"2022-12-30","current":-4.920298,"twenty":-4.963438,"median":-3.442407,"eighty":-2.532833,"marketCap":5796096108},{"date":"2023-01-06","current":-5.696215,"twenty":-4.986152,"median":-3.459421,"eighty":-2.537937,"marketCap":6710123779},{"date":"2023-01-13","current":-6.078015,"twenty":-5.062436,"median":-3.489823,"eighty":-2.548887,"marketCap":7159883427},{"date":"2023-01-20","current":-5.406785,"twenty":-5.233449,"median":-3.502516,"eighty":-2.555534,"marketCap":6369176949},{"date":"2023-01-27","current":-5.26515,"twenty":-5.262806,"median":-3.539206,"eighty":-2.566009,"marketCap":6202330628},{"date":"2023-02-03","current":-4.803295,"twenty":-5.259893,"median":-3.564922,"eighty":-2.571113,"marketCap":5658266538},{"date":"2023-02-10","current":-5.115464,"twenty":-5.244212,"median":-3.604662,"eighty":-2.574941,"marketCap":6026001052},{"date":"2023-02-17","current":-5.249117,"twenty":-5.262806,"median":-3.622956,"eighty":-2.577493,"marketCap":6537643757},{"date":"2023-02-24","current":-4.707155,"twenty":-5.260343,"median":-3.647828,"eighty":-2.578769,"marketCap":5862643415},{"date":"2023-03-03","current":-4.902017,"twenty":-5.255042,"median":-3.686206,"eighty":-2.581959,"marketCap":6105340167},{"date":"2023-03-10","current":-4.658439,"twenty":-5.243214,"median":-3.722442,"eighty":-2.58884,"marketCap":5801969227},{"date":"2023-03-17","current":-5.297833,"twenty":-5.243214,"median":-3.739024,"eighty":-2.598979,"marketCap":6598317945},{"date":"2023-03-24","current":-4.213908,"twenty":-5.243214,"median":-3.8468,"eighty":-2.606589,"marketCap":5248317262},{"date":"2023-03-31","current":-4.494023,"twenty":-5.232955,"median":-3.897301,"eighty":-2.613481,"marketCap":5597193843},{"date":"2023-04-06","current":-4.329608,"twenty":-5.228412,"median":-3.950432,"eighty":-2.619601,"marketCap":5392418458},{"date":"2023-04-14","current":-4.627992,"twenty":-5.217919,"median":-4.01261,"eighty":-2.637464,"marketCap":5764047860},{"date":"2023-04-21","current":-5.358727,"twenty":-5.233657,"median":-4.051523,"eighty":-2.647672,"marketCap":6674160680},{"date":"2023-04-28","current":-5.133417,"twenty":-5.258992,"median":-4.076932,"eighty":-2.647672,"marketCap":6393542560},{"date":"2023-05-05","current":-5.115149,"twenty":-5.249117,"median":-4.210756,"eighty":-2.654052,"marketCap":6370789740},{"date":"2023-05-12","current":-5.510964,"twenty":-5.261296,"median":-4.226706,"eighty":-2.654128,"marketCap":6863767517},{"date":"2023-05-19","current":-5.535322,"twenty":-5.302098,"median":-4.268175,"eighty":-2.724231,"marketCap":6894104611},{"date":"2023-05-26","current":-5.620574,"twenty":-5.32219,"median":-4.304491,"eighty":-2.730611,"marketCap":7000284440},{"date":"2023-05-31","current":-5.523143,"twenty":-5.32219,"median":-4.313728,"eighty":-2.730611,"marketCap":6878936064},{"date":"2023-06-09","current":-5.833705,"twenty":-5.36774,"median":-4.329608,"eighty":-2.730865,"marketCap":7265734013},{"date":"2023-06-16","current":-6.040747,"twenty":-5.386985,"median":-4.34784,"eighty":-2.731246,"marketCap":7523599312},{"date":"2023-06-23","current":-6.071194,"twenty":-5.402439,"median":-4.369153,"eighty":-2.743893,"marketCap":7561520679},{"date":"2023-06-30","current":-7.523496,"twenty":-5.414714,"median":-4.379957,"eighty":-2.752698,"marketCap":7591433186},{"date":"2023-07-07","current":-8.093458,"twenty":-5.42245,"median":-4.39535,"eighty":-2.763985,"marketCap":8166541761},{"date":"2023-07-10","current":-8.20745,"twenty":-5.426692,"median":-4.40302,"eighty":-2.769628,"marketCap":8281563476},{"date":"2023-07-21","current":-8.458233,"twenty":-5.426692,"median":-4.411894,"eighty":-2.775271,"marketCap":8534611249},{"date":"2023-07-28","current":-8.20745,"twenty":-5.456159,"median":-4.423904,"eighty":-2.776851,"marketCap":8281563476},{"date":"2023-08-02","current":-9.084475,"twenty":-5.504874,"median":-4.43381,"eighty":-2.779221,"marketCap":9166507826},{"date":"2023-08-11","current":-8.673275,"twenty":-5.533128,"median":-4.451397,"eighty":-2.781165,"marketCap":8751594647},{"date":"2023-08-17","current":-8.609097,"twenty":-5.568907,"median":-4.464601,"eighty":-2.789307,"marketCap":8342533149},{"date":"2023-08-25","current":-8.848017,"twenty":-5.635672,"median":-4.494023,"eighty":-2.794411,"marketCap":8574055808},{"date":"2023-09-01","current":-9.214361,"twenty":-5.70006,"median":-4.494023,"eighty":-2.796878,"marketCap":8929057219},{"date":"2023-09-08","current":-9.317894,"twenty":-5.725205,"median":-4.506954,"eighty":-2.804955,"marketCap":9029383704},{"date":"2023-09-15","current":-9.150649,"twenty":-5.757588,"median":-4.518382,"eighty":-2.830689,"marketCap":8867317843},{"date":"2023-09-19","current":-8.855981,"twenty":-5.782386,"median":-4.524471,"eighty":-2.831089,"marketCap":8581773230},{"date":"2023-10-05","current":-7.985677,"twenty":-5.795976,"median":-4.528872,"eighty":-2.831489,"marketCap":7738416687},{"date":"2023-10-09","current":-8.819584,"twenty":-5.801844,"median":-4.533273,"eighty":-2.83189,"marketCap":8546503125},{"date":"2023-11-10","current":-6.982171,"twenty":-5.878767,"median":-4.593193,"eighty":-2.839209,"marketCap":6765981641},{"date":"2023-11-17","current":-7.385988,"twenty":-5.911027,"median":-4.599453,"eighty":-2.843555,"marketCap":7251370631},{"date":"2023-11-24","current":-7.476061,"twenty":-5.936844,"median":-4.606312,"eighty":-2.848702,"marketCap":7339801980},{"date":"2023-12-01","current":-7.828164,"twenty":-5.955617,"median":-4.626958,"eighty":-2.858995,"marketCap":7685488163},{"date":"2023-12-08","current":-7.983745,"twenty":-6.044634,"median":-4.632542,"eighty":-2.865429,"marketCap":7838233221},{"date":"2023-12-15","current":-9.113752,"twenty":-6.115375,"median":-4.64756,"eighty":-2.880169,"marketCap":8947644692},{"date":"2023-12-22","current":-8.630633,"twenty":-6.163796,"median":-4.652396,"eighty":-2.903623,"marketCap":8473331092},{"date":"2023-12-29","current":-9.310275,"twenty":-6.191639,"median":-4.65697,"eighty":-2.914323,"marketCap":9140585817},{"date":"2024-01-05","current":-8.85991,"twenty":-6.278622,"median":-4.665632,"eighty":-2.914323,"marketCap":8698429071},{"date":"2024-01-12","current":-8.999114,"twenty":-6.411262,"median":-4.682797,"eighty":-2.933623,"marketCap":8835095702},{"date":"2024-01-19","current":-8.606068,"twenty":-6.622001,"median":-4.702881,"eighty":-2.951636,"marketCap":8449213451},{"date":"2024-01-26","current":-8.614256,"twenty":-6.787201,"median":-4.725193,"eighty":-2.964833,"marketCap":8457252665},{"date":"2024-02-02","current":-8.229399,"twenty":-7.069423,"median":-4.752459,"eighty":-2.973569,"marketCap":8079409627},{"date":"2024-02-09","current":-8.655198,"twenty":-7.254542,"median":-4.792407,"eighty":-2.978932,"marketCap":8497448732},{"date":"2024-02-16","current":2.065844,"twenty":-7.303922,"median":-4.780228,"eighty":-2.964833,"marketCap":9226936768},{"date":"2024-02-23","current":2.049606,"twenty":-7.257183,"median":-4.752459,"eighty":-2.914323,"marketCap":9154410628},{"date":"2024-03-01","current":2.06404,"twenty":-7.238464,"median":-4.725193,"eighty":-2.857709,"marketCap":9218878308},{"date":"2024-03-08","current":2.011717,"twenty":-7.203572,"median":-4.702881,"eighty":-2.831089,"marketCap":8985182966},{"date":"2024-03-15","current":1.845728,"twenty":-7.17056,"median":-4.682797,"eighty":-2.784203,"marketCap":8243804641},{"date":"2024-03-22","current":1.851141,"twenty":-7.072124,"median":-4.662035,"eighty":-2.734408,"marketCap":8267980021},{"date":"2024-03-28","current":1.955786,"twenty":-7.061318,"median":-4.653949,"eighty":-2.724231,"marketCap":8735370705},{"date":"2024-04-05","current":2.07667,"twenty":-7.041464,"median":-4.649343,"eighty":-2.647672,"marketCap":9275287529},{"date":"2024-04-12","current":2.015326,"twenty":-6.982171,"median":-4.633193,"eighty":-2.603013,"marketCap":9001299887},{"date":"2024-04-19","current":1.869183,"twenty":-6.836309,"median":-4.627992,"eighty":-2.577493,"marketCap":8348564622},{"date":"2024-04-26","current":1.963003,"twenty":-6.71354,"median":-4.606312,"eighty":-2.558353,"marketCap":8767604545},{"date":"2024-05-03","current":2.027955,"twenty":-6.670861,"median":-4.599453,"eighty":-2.532833,"marketCap":9057709107},{"date":"2024-05-10","current":2.02976,"twenty":-6.650279,"median":-4.593193,"eighty":-2.494554,"marketCap":9065767567},{"date":"2024-05-17","current":2.058627,"twenty":-6.642371,"median":-4.533273,"eighty":-2.462654,"marketCap":9194702928},{"date":"2024-05-24","current":1.973829,"twenty":-6.591446,"median":-4.51,"eighty":-2.454908,"marketCap":8815955305},{"date":"2024-05-31","current":1.718448,"twenty":-6.564974,"median":-4.500113,"eighty":-2.434582,"marketCap":7675319574},{"date":"2024-06-07","current":1.803946,"twenty":-6.454764,"median":-4.494023,"eighty":-2.405157,"marketCap":7845225590},{"date":"2024-06-14","current":1.83622,"twenty":-6.411262,"median":-4.475755,"eighty":-2.37522,"marketCap":7985582733},{"date":"2024-06-21","current":1.834521,"twenty":-6.357491,"median":-4.458443,"eighty":-2.36232,"marketCap":7978195515},{"date":"2024-06-28","current":1.795452,"twenty":-6.315456,"median":-4.451397,"eighty":-2.359299,"marketCap":7808289499},{"date":"2024-07-05","current":1.780165,"twenty":-6.293959,"median":-4.43381,"eighty":-2.336521,"marketCap":7741804537},{"date":"2024-07-12","current":1.909261,"twenty":-6.284629,"median":-4.411894,"eighty":-2.31496,"marketCap":8303233110},{"date":"2024-07-15","current":1.927946,"twenty":-6.281626,"median":-4.40302,"eighty":-2.312728,"marketCap":8384492509},{"date":"2024-08-02","current":1.805074,"twenty":-6.278622,"median":-4.39535,"eighty":-2.309536,"marketCap":7850132402},{"date":"2024-08-09","current":1.693429,"twenty":-6.278622,"median":-4.366072,"eighty":-2.252116,"marketCap":8020144685},{"date":"2024-08-16","current":1.766031,"twenty":-6.246992,"median":-4.329608,"eighty":-2.236408,"marketCap":8363991829},{"date":"2024-08-23","current":1.823806,"twenty":-6.191639,"median":-4.316807,"eighty":-2.107879,"marketCap":8637614904},{"date":"2024-08-30","current":1.876896,"twenty":-6.183731,"median":-4.292175,"eighty":-2.071549,"marketCap":8889052324},{"date":"2024-09-06","current":1.903441,"twenty":-6.177405,"median":-4.262355,"eighty":-2.013004,"marketCap":9014771034},{"date":"2024-09-13","current":1.892511,"twenty":-6.151768,"median":-4.223516,"eighty":-1.918435,"marketCap":8963004506},{"date":"2024-09-20","current":1.861281,"twenty":-6.131704,"median":-4.204376,"eighty":1.697441,"marketCap":8815100142},{"date":"2024-09-27","current":1.806629,"twenty":-6.122015,"median":-4.064326,"eighty":1.738237,"marketCap":8556267503},{"date":"2024-10-04","current":1.750416,"twenty":-6.120471,"median":-4.028928,"eighty":1.751704,"marketCap":8290039647},{"date":"2024-10-11","current":1.853474,"twenty":-6.110279,"median":-4.000218,"eighty":1.762284,"marketCap":8778124050},{"date":"2024-10-18","current":1.85972,"twenty":-6.083958,"median":-3.901446,"eighty":1.777262,"marketCap":8807704923},{"date":"2024-10-25","current":1.842543,"twenty":-6.072558,"median":-3.879584,"eighty":1.781575,"marketCap":8726357523},{"date":"2024-10-31","current":1.83942,"twenty":-6.056813,"median":-3.805687,"eighty":1.791991,"marketCap":8711567086},{"date":"2024-11-08","current":1.836298,"twenty":-6.043338,"median":-3.726587,"eighty":1.795307,"marketCap":8696776650},{"date":"2024-11-15","current":1.761541,"twenty":-6.022157,"median":-3.710504,"eighty":1.796132,"marketCap":8473335020},{"date":"2024-11-22","current":1.788782,"twenty":-5.980856,"median":-3.669625,"eighty":1.795452,"marketCap":8604365974},{"date":"2024-11-29","current":1.92347,"twenty":-5.959401,"median":-3.641728,"eighty":1.799135,"marketCap":9252241246},{"date":"2024-12-06","current":1.828129,"twenty":-5.955617,"median":-3.621995,"eighty":1.805651,"marketCap":8793632907},{"date":"2024-12-13","current":1.797862,"twenty":-5.950068,"median":-3.584982,"eighty":1.808349,"marketCap":8648042958},{"date":"2024-12-20","current":1.740355,"twenty":-5.940624,"median":-3.556632,"eighty":1.808807,"marketCap":8371422056},{"date":"2024-12-27","current":1.816022,"twenty":-5.937226,"median":-3.538361,"eighty":1.814437,"marketCap":8735396928},{"date":"2025-01-03","current":1.828129,"twenty":-5.937226,"median":-3.502516,"eighty":1.814437,"marketCap":8793632907},{"date":"2025-01-10","current":1.667714,"twenty":-5.936463,"median":-3.489823,"eighty":1.814437,"marketCap":8022006178},{"date":"2025-01-17","current":1.64804,"twenty":-5.931806,"median":-3.459421,"eighty":1.81012,"marketCap":7927372712},{"date":"2025-01-24","current":1.696467,"twenty":-5.919996,"median":-3.442407,"eighty":1.808689,"marketCap":8160316630},{"date":"2025-01-31","current":1.720681,"twenty":-5.911027,"median":-3.427114,"eighty":1.808297,"marketCap":8276788589},{"date":"2025-02-07","current":1.645013,"twenty":-5.893917,"median":-3.410632,"eighty":1.807254,"marketCap":7912813717},{"date":"2025-02-14","current":-63.938672,"twenty":-5.936654,"median":-3.427114,"eighty":1.806273,"marketCap":7456591836},{"date":"2025-02-21","current":-65.590676,"twenty":-5.950068,"median":-3.43596,"eighty":1.805651,"marketCap":7649250189},{"date":"2025-02-28","current":-63.510374,"twenty":-6.028354,"median":-3.459421,"eighty":1.804623,"marketCap":7406643374},{"date":"2025-03-07","current":-64.856452,"twenty":-6.095845,"median":-3.489823,"eighty":1.803146,"marketCap":7563624254},{"date":"2025-03-14","current":-63.755116,"twenty":-6.138729,"median":-3.504703,"eighty":1.801321,"marketCap":7435185352},{"date":"2025-03-21","current":-67.120309,"twenty":-6.224851,"median":-3.540051,"eighty":1.799375,"marketCap":7827637554},{"date":"2025-03-28","current":-64.122228,"twenty":-6.294119,"median":-3.568302,"eighty":1.797622,"marketCap":7477998319},{"date":"2025-04-04","current":-61.246517,"twenty":-6.57821,"median":-3.611042,"eighty":1.797217,"marketCap":7142630074},{"date":"2025-04-11","current":-59.043845,"twenty":-6.696468,"median":-3.629292,"eighty":1.796471,"marketCap":6885752269},{"date":"2025-04-17","current":-61.307702,"twenty":-7.029605,"median":-3.656118,"eighty":1.795452,"marketCap":7149765569},{"date":"2025-04-25","current":-67.303865,"twenty":-7.203572,"median":-3.697571,"eighty":1.795404,"marketCap":7849044038},{"date":"2025-05-02","current":-70.852614,"twenty":-7.3427,"median":-3.722442,"eighty":1.794996,"marketCap":8262902723},{"date":"2025-05-09","current":-67.487421,"twenty":-7.407161,"median":-3.747314,"eighty":1.793826,"marketCap":7870450521},{"date":"2025-05-16","current":-65.835417,"twenty":-7.440032,"median":-3.863192,"eighty":1.792576,"marketCap":7677792168},{"date":"2025-05-23","current":-66.936753,"twenty":-7.514009,"median":-3.898058,"eighty":1.792422,"marketCap":7806231070},{"date":"2025-05-30","current":-44.666612,"twenty":-7.615264,"median":-3.996029,"eighty":1.791808,"marketCap":7681808591},{"date":"2025-06-06","current":-44.271332,"twenty":-7.828164,"median":-4.012794,"eighty":1.791601,"marketCap":7613827984},{"date":"2025-06-13","current":-45.338588,"twenty":-7.985677,"median":-4.058168,"eighty":1.790295,"marketCap":7797375622},{"date":"2025-06-20","current":-45.220004,"twenty":-8.052528,"median":-4.089537,"eighty":1.789085,"marketCap":7776981440},{"date":"2025-06-27","current":-45.852451,"twenty":-8.132775,"median":-4.212332,"eighty":1.786858,"marketCap":7885750412},{"date":"2025-07-03","current":-43.441245,"twenty":-8.195007,"median":-4.226706,"eighty":1.786004,"marketCap":7471068709},{"date":"2025-07-11","current":-45.733867,"twenty":-8.236009,"median":-4.268175,"eighty":1.785163,"marketCap":7865356229},{"date":"2025-07-18","current":-46.050091,"twenty":-8.440661,"median":-4.304491,"eighty":1.782373,"marketCap":7919740715},{"date":"2025-07-25","current":-44.982836,"twenty":-8.475052,"median":-4.317429,"eighty":1.780409,"marketCap":7736193076},{"date":"2025-08-01","current":-44.90378,"twenty":-8.532372,"median":-4.34784,"eighty":1.780165,"marketCap":7722596955},{"date":"2025-08-08","current":-45.837033,"twenty":-8.611161,"median":-4.372234,"eighty":1.779146,"marketCap":7883098769},{"date":"2025-08-15","current":-16.34542,"twenty":-8.663439,"median":-4.411894,"eighty":1.777563,"marketCap":8019602644},{"date":"2025-08-22","current":-16.428886,"twenty":-8.766224,"median":-4.43381,"eighty":1.776024,"marketCap":8060553806},{"date":"2025-08-29","current":-16.618548,"twenty":-8.845327,"median":-4.45492,"eighty":1.774463,"marketCap":8153608011},{"date":"2025-09-05","current":-17.495406,"twenty":-8.854277,"median":-4.470178,"eighty":1.771946,"marketCap":8583823509},{"date":"2025-09-12","current":-20.056388,"twenty":-8.876687,"median":-4.494023,"eighty":1.769108,"marketCap":9840325916},{"date":"2025-09-19","current":-21.002838,"twenty":-8.897577,"median":-4.500113,"eighty":1.767877,"marketCap":10304685501},{"date":"2025-09-26","current":-20.821899,"twenty":-8.942703,"median":-4.512292,"eighty":1.764235,"marketCap":10215910875},{"date":"2025-10-03","current":-22.241574,"twenty":-9.033505,"median":-4.556436,"eighty":1.761541,"marketCap":10912450253},{"date":"2025-10-10","current":-22.436432,"twenty":-9.13201,"median":-4.593552,"eighty":1.761463,"marketCap":11008053697},{"date":"2025-10-17","current":-24.093621,"twenty":-9.171002,"median":-4.599453,"eighty":1.761347,"marketCap":11821125436},{"date":"2025-10-24","current":-25.515863,"twenty":-9.267695,"median":-4.606312,"eighty":1.759121,"marketCap":12518924190},{"date":"2025-10-31","current":-27.571776,"twenty":-9.314846,"median":-4.630267,"eighty":1.753849,"marketCap":13527623380},{"date":"2025-11-07","current":-28.965855,"twenty":-9.38078,"median":-4.633845,"eighty":1.750842,"marketCap":14211604337},{"date":"2025-11-14","current":-38.236714,"twenty":-16.050507,"median":-4.650846,"eighty":1.750577,"marketCap":14299307604},{"date":"2025-11-21","current":-37.697383,"twenty":-16.342611,"median":-4.655501,"eighty":1.750416,"marketCap":14097615036},{"date":"2025-11-28","current":-38.701655,"twenty":-16.456526,"median":-4.665632,"eighty":1.749791,"marketCap":14473180508},{"date":"2025-12-05","current":-39.389767,"twenty":-16.615764,"median":-4.682797,"eighty":1.746981,"marketCap":14730512405},{"date":"2025-12-12","current":-39.687329,"twenty":-17.4453,"median":-4.707155,"eighty":1.745262,"marketCap":14841791064},{"date":"2025-12-19","current":-40.524222,"twenty":-18.606093,"median":-4.731811,"eighty":1.743078,"marketCap":15154762290},{"date":"2025-12-26","current":-41.844653,"twenty":-19.597082,"median":-4.752459,"eighty":1.741868,"marketCap":15648561337},{"date":"2026-01-02","current":-40.356843,"twenty":-20.471156,"median":-4.780228,"eighty":1.740658,"marketCap":15092168045},{"date":"2026-01-09","current":-40.505624,"twenty":-20.947164,"median":-4.79799,"eighty":1.739144,"marketCap":15147807374},{"date":"2026-01-16","current":-43.332463,"twenty":-21.144805,"median":-4.80726,"eighty":1.736859,"marketCap":16204954629},{"date":"2026-01-23","current":-42.718742,"twenty":-22.269411,"median":-4.820349,"eighty":1.732402,"marketCap":15975442396},{"date":"2026-01-30","current":-40.951967,"twenty":-22.464268,"median":-4.839442,"eighty":1.729057,"marketCap":15314725362},{"date":"2026-02-06","current":-39.315377,"twenty":-23.265544,"median":-4.869723,"eighty":1.723844,"marketCap":14702692741},{"date":"2026-02-09","current":-22.835504,"twenty":-23.053332,"median":-4.886887,"eighty":1.722262,"marketCap":18479403357}],"updateTime":1770743419016},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ROIV\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1176652125","title":"異動解讀 | 旗下藥物二期研究顯示積極成果，Roivant Sciences盤中大漲5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=1176652125","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176652125?lang=zh_tw&edition=fundamental","pubTime":"2026-02-10 04:09","pubTimestamp":1770667748,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd.  今日盘中股价大幅上涨5.02%，引起了市场的关注。消息面上，公司旗下Priovant Therapeutics公司宣布，其试验药物brepocitinib在针对皮肤结节病的二期研究中显示出积极成果。研究数据显示，在较高剂量下，患者的皮肤活动性得到显著改善。此外，公司另一家子公司Pulmovant也已完成针对肺动脉高压的实验性药物mosliciguat的二期试验患者招募工作。Priovant表示，计划在与美国食品药品监督管理局协商后，于2026年启动brepocitinib的第三阶段试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ROIV"],"gpt_icon":0},{"id":"1108390468","title":"異動解讀 | 候選藥物二期數據積極疊加財報亮眼，Roivant Sciences盤中大漲19.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=1108390468","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108390468?lang=zh_tw&edition=fundamental","pubTime":"2026-02-06 22:58","pubTimestamp":1770389893,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd.  今日盘中大涨19.68%，引起了市场的广泛关注。消息面上，公司公布了其候选药物Brepocitinib在治疗皮肤结节病的二期临床试验中取得突破性进展，达到主要疗效终点，患者皮肤病变严重程度获得显著改善。临床数据显示，Brepocitinib作为口服TYK2/JAK1抑制剂，在12周治疗期内表现出优越的安全性与耐受性。财务方面，本季度研发支出集中投向核心管线推进，其中Brepocitinib项目获得重点资源倾斜。这些积极进展共同提振了市场信心，推动了股价的显著上扬。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ROIV"],"gpt_icon":0},{"id":"1133289755","title":"Roivant股價盤前飆升15.8%，實驗性藥物對罕見皮膚病顯效及三季度業績提振市場信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1133289755","media":"美股速递","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133289755?lang=zh_tw&edition=fundamental","pubTime":"2026-02-06 20:59","pubTimestamp":1770382753,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd. (ROIV) 股价在盘前交易时段大幅跃升15.8%，此番强劲表现主要受到两大利好因素驱动：其一，公司旗下实验性药物在针对一种罕见皮肤病的临床试验中展现出积极疗效；其二，公司最新公布的第三季度财务业绩超出市场预期。这两项进展共同点燃了投资者的热情，推动股价显著上扬。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ROIV","BK4007"],"gpt_icon":0},{"id":"1185422472","title":"異動解讀 | 候選藥物二期數據積極疊加財報亮眼，Roivant Sciences盤前大漲9.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=1185422472","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185422472?lang=zh_tw&edition=fundamental","pubTime":"2026-02-06 20:09","pubTimestamp":1770379795,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd.  今日盘前股价大涨9.93%，引起了市场的广泛关注。消息面上，公司公布了其候选药物Brepocitinib在治疗皮肤结节病的二期临床试验中取得突破性进展，达到主要疗效终点，患者皮肤病变严重程度获得显著改善。临床数据显示，Brepocitinib作为口服TYK2/JAK1抑制剂，在12周治疗期内表现出优越的安全性与耐受性。财务方面，本季度研发支出集中投向核心管线推进，其中Brepocitinib项目获得重点资源倾斜。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ROIV"],"gpt_icon":0},{"id":"1148492221","title":"Roivant公布Brepocitinib治療皮膚結節病的二期積極數據 同步披露2025財年第三季度業績","url":"https://stock-news.laohu8.com/highlight/detail?id=1148492221","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148492221?lang=zh_tw&edition=fundamental","pubTime":"2026-02-06 20:07","pubTimestamp":1770379626,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd.  近日宣布其候选药物Brepocitinib在皮肤结节病治疗领域的二期临床试验取得突破性进展。该研究达到主要疗效终点，患者皮肤病变严重程度获得显著改善。与此同时，公司公布了截至2025年12月31日的第三季度财务报告，研发投入与营收增长呈现良性互动态势。临床数据显示，Brepocitinib作为口服TYK2/JAK1抑制剂，在12周治疗期内表现出优越的安全性与耐受性特征。财务方面，本季度研发支出集中投向核心管线推进，其中Brepocitinib项目获得重点资源倾斜。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","ROIV"],"gpt_icon":0},{"id":"1183978683","title":"Priovant計劃與FDA溝通後推進關鍵項目，三期臨牀試驗擬於2026年啓動","url":"https://stock-news.laohu8.com/highlight/detail?id=1183978683","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183978683?lang=zh_tw&edition=fundamental","pubTime":"2026-02-06 20:05","pubTimestamp":1770379512,"startTime":"0","endTime":"0","summary":"生物制药公司Priovant近日宣布，在与美国食品药品监督管理局（FDA）进行深入交流后，公司计划将其核心项目Cs推进至关键阶段。根据最新规划，该项目预计将于2026年正式启动三期临床试验。这一进展标志着该疗法向商业化应用迈出重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ROIV","BK4139"],"gpt_icon":0},{"id":"1190098299","title":"Pulmovant宣佈完成Mosliciguat治療間質性肺病相關肺動脈高壓二期Phocus研究患者入組","url":"https://stock-news.laohu8.com/highlight/detail?id=1190098299","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190098299?lang=zh_tw&edition=fundamental","pubTime":"2026-02-06 20:02","pubTimestamp":1770379352,"startTime":"0","endTime":"0","summary":"生物制药公司Pulmovant今日宣布，其针对间质性肺病相关肺动脉高压（PH-ILD）研发的创新药物Mosliciguat，已顺利完成二期临床试验Phocus研究的全部患者招募工作。该里程碑标志着药物临床开发进入关键数据收集阶段，为后续疗效评估奠定基础。\n本研究旨在评估Mosliciguat在PH-ILD患者中的安全性、耐受性及初步疗效。作为一款选择性可溶性鸟苷酸环化酶激动剂，该药物通过独特作用机制靶向肺动脉高压的病理生理过程。此次完成入组将加速临床试验进程，相关数据结果预计于2024年公布。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","ROIV"],"gpt_icon":0},{"id":"1151708126","title":"財報前瞻｜Roivant Sciences Ltd.本季度營收或下滑，機構觀點偏謹慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1151708126","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151708126?lang=zh_tw&edition=fundamental","pubTime":"2026-01-30 10:04","pubTimestamp":1769738699,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd.将于2026年02月06日发布最新季度财报，市场关注营收构成与费用去化的节奏以及管线驱动的业绩弹性与不确定性。- 一致预期显示本季度Revenue预计为646.73万美元，同比下降59.52%；EBIT预计为-3.06亿美元，同比变动-11.34%；EPS预计为-0.32美元，同比变动-12.88%。基于近期卖方对Roivant Sciences Ltd.的评论与评级动向，市场观点以中性偏谨慎为主，占比较高的观点集中在“短期营收波动与费用刚性导致利润压力仍存”，并强调需要更多来自管线与里程碑的可验证催化。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻｜Roivant Sciences Ltd.本季度营收或下滑，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV"],"gpt_icon":0},{"id":"2606279517","title":"2026年最有價值的管線資產排名","url":"https://stock-news.laohu8.com/highlight/detail?id=2606279517","media":"药智网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606279517?lang=zh_tw&edition=fundamental","pubTime":"2026-01-27 10:37","pubTimestamp":1769481473,"startTime":"0","endTime":"0","summary":"通过对医药开发管线进行系统性的NPV排名，能够以前瞻性的财务视角剖析各大药企的战略底牌。当前处于III期，2026年将公布多项顶线数据。临床推进节奏已经很清晰：诺和公开计划在2026年第一季度启动口服与皮下制剂的III期项目。2026年的临床读数将直接决定这条机制路线能否兑现“更安全抗凝”的差异化主张。公司披露的给药方案为每周皮下注射600 mg，最长治疗52周。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127104114a6b0efbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127104114a6b0efbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","BK4512","LU1861220033.SGD","JNJ","BK4141","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4007","LLY","LU1861214812.USD","LU2360107325.USD","IE00BFMHRM44.USD","LU0724618433.USD","RHHBY","IE00BD6J9T35.USD","LU1093756168.USD","LU1093756325.SGD","ROIV","APGE","NVO","LU1720051108.HKD","LU0348723411.USD","LU1861219969.SGD","LU1861215975.USD","LU1854104046.USD","AMGN","04332","RVMD","LU1548497426.USD","BK4605","BMY","LU2298322129.HKD","LU2357305700.SGD","BK4532","BK4585","IE00BZ199S13.USD","LU1854103824.USD","LU1720051017.SGD","LU0124384867.USD","IMVT","BK4588","LU1978683503.SGD"],"gpt_icon":1},{"id":"1136775542","title":"Roivant Sciences將於2026年2月6日公布2025財年第三季度業績並舉行業務更新會","url":"https://stock-news.laohu8.com/highlight/detail?id=1136775542","media":"美股速递","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136775542?lang=zh_tw&edition=fundamental","pubTime":"2026-01-24 05:15","pubTimestamp":1769202912,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd. (ROIV) 计划于2026年2月6日（星期五）发布其截至2025年12月31日的2025财年第三季度财务业绩报告。届时，公司管理层还将同步举行业务更新会议，向投资者和市场详细通报公司的最新运营进展与战略规划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV","BK4007","BK4139"],"gpt_icon":0},{"id":"2603635831","title":"Ro 與安進公司合作，研究肥胖症護理和 GLP-1 獲取的障礙","url":"https://stock-news.laohu8.com/highlight/detail?id=2603635831","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603635831?lang=zh_tw&edition=fundamental","pubTime":"2026-01-13 23:20","pubTimestamp":1768317614,"startTime":"0","endTime":"0","summary":"路透1月13日 - 美国远程医疗公司Ro周二表示，它已与制药商安进AMGN.O开展了一项研究合作，探讨患者和医疗服务提供者在获得包括GLP-1疗法在内的肥胖症治疗方面面临的挑战。这项研究将利用Ro公司直接面向消费者平台的数据，跟踪诺和诺德NOVOb.CO的Ozempic和礼来LLY.N的Zepbound等GLP-1药物的保险范围和预先授权要求。罗说，减肥药重塑了肥胖症治疗，但由于医保缺口，许多患者仍难以获得减肥药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nL4S3YE1JN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443465.HKD","LU2023250504.SGD","BK4139","LU1093756168.USD","LU0203201768.USD","IE00BKDWB100.SGD","LU1064131342.USD","IE00BK4W5L77.USD","LU0234572021.USD","LU0466842654.USD","ROIV","LU1720051017.SGD","SG9999018865.SGD","LU0316494557.USD","LU0456855351.SGD","LU2746668461.USD","LU0823434740.USD","LU2237443382.USD","AMGN","LU2552382058.USD","LU0256863902.USD","IE00B4JS1V06.HKD","LU1267930730.SGD","LU0432979614.USD","LU1551013342.USD","LU0823416689.USD","LU2471134523.USD","LU0417517546.SGD","LU1917777945.USD","IE00BJT1NW94.SGD","SG9999014880.SGD","LU2552382215.SGD","LU1868837136.USD","IE00B4R5TH58.HKD","LU2324357040.USD","SGXZ81514606.USD","04332","LU0266013472.USD","LU0106261372.USD","LU2063271972.USD","LU0868494617.USD","IE00B1BXHZ80.USD","IE00BWXC8680.SGD","LU0353189763.USD","LU0683600562.USD","LU0708995401.HKD","LU1712237335.SGD","LU2237443978.SGD","LU1868836591.USD","LU0354030438.USD","LU0320765059.SGD","LU0109391861.USD","LU2471134952.CNY","SG9999015952.SGD","LU1069344957.HKD","GB00BDT5M118.USD","LU1868836757.USD","LU0471298777.SGD","LU2461242641.AUD","LU0943347566.SGD","IE00BJJMRY28.SGD","BK4533","IE00B2B36J28.USD","LU1623119135.USD","LU0006306889.USD","LU1551013425.SGD","LU1804176565.USD","SG9999015945.SGD","BK4516","IE00BJJMRX11.SGD","SGXZ99366536.SGD","LU2602419157.SGD","BK4534","LU2417539215.USD","LU1988902786.USD","LU0787776722.HKD","BK4599","IE0009355771.USD","LU0198837287.USD","LU0385154629.USD","LU2237443622.USD","LU2237443895.HKD","LU1127390331.HKD","IE00B775H168.HKD","LU2360106947.USD","LU2471134796.USD","LU2471134879.HKD","BK4007","LU2361044865.SGD","LU0640476718.USD","LU1571399168.USD","LU1989771016.USD","IE00B7KXQ091.USD","LU2237438978.USD","LU2552382132.HKD","LU2089984988.USD","LU0096364046.USD","LU1366192091.USD","LU2211815571.USD","LU1323610961.USD","LU1983299246.USD","IE00BFSS8Q28.SGD","LU2168564149.EUR","LU2242652126.USD","LU0320765992.SGD","LU2264538146.SGD","LU0882574055.USD","IE0002141913.USD","IE00BN29S564.USD","LU2361045086.USD","IE00BFSS7M15.SGD","IE00BKPKM429.USD","LU0238689110.USD","LU2361044949.HKD","SGXZ31699556.SGD","LU1057294990.SGD","LU2087625088.SGD","LU2242646821.SGD","LU0079474960.USD","LU1720051108.HKD","LU0122379950.USD","LU2236285917.USD","SG9999014898.SGD","LU2168564065.EUR","LU0689472784.USD","LU0094547139.USD","BK4581","LU0225283273.USD","LU0323591593.USD","LU1814569148.SGD","IE00BFTCPJ56.SGD","LU2750360641.GBP","LU1868837300.USD","LU1093756325.SGD","SG9999014906.USD","BK4192","IE00BJJMRZ35.SGD","SG9999017495.SGD","SG9999014914.USD","LU2491050071.SGD","IE00BK4W5M84.HKD","LU2106854487.HKD","LU2237443549.SGD","LU2462157665.USD","LU2746668974.SGD","LU2357305700.SGD","SG9999015986.USD","LU1974910355.USD","LU0114720955.EUR","IE0004445239.USD","LU1035775433.USD","LU0109394709.USD","LU0061475181.USD","LU2168563687.JPY","LU2750360997.AUD","LU0786609619.USD","LU0058720904.USD","LU0097036916.USD","SG9999001176.USD","IE0005OL40V9.USD","LU2168564495.EUR","SG9999018857.SGD","LU0353189680.USD","LU1061106388.HKD","SG9999015978.USD","LU0289739699.SGD","LU0672654240.SGD","LU2456880835.USD","LU1232071149.USD","LU1868836914.USD","LU2491049909.HKD","LU0256863811.USD","IE00BJLML261.HKD","LU0820561909.HKD","LU2265009873.SGD","IE00B1XK9C88.USD","SG9999013999.USD","BK4588","LU0471298694.HKD","SG9999001176.SGD","SG9999001440.SGD","LU0889565916.HKD","IE0004445015.USD","LU1023059063.AUD","LU1280957306.USD","LU2112291526.USD","LU1548497426.USD","LU2168564222.USD","LU2468319806.SGD","SGXZ57979304.SGD","LU0820561818.USD","LU0882574139.USD","SGXZ51526630.SGD","BK4566","BK4585","LU0823434583.USD","LU1291159041.SGD","LU2491050154.USD","LU0354030511.USD","LU2108987350.USD","LU0203202063.USD"],"gpt_icon":0},{"id":"2595726511","title":"Jefferies：Roivant(ROIV.US)2026年迎三大催化劑，目標價看高至 24 美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595726511","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595726511?lang=zh_tw&edition=fundamental","pubTime":"2025-12-31 14:41","pubTimestamp":1767163270,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，Jefferies发布深度研报，聚焦生物技术公司Roivant Sciences的投资前景，通过严谨的财务模型与行业分析，揭示了其未来三大核心催化剂及估值逻辑。研报指出，2026年将成为公司关键转折点，三大催化剂或推动股价显著上行。第三项催化剂为Priovant的brepo药物三期NIU试验数据，其时间节点提前至2026年下半年。基于此，Jefferies给予Roivant“买入”评级，目标价24美元，较最新收盘价21.63美元有10.95%上行空间。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1387617.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Jefferies：Roivant(ROIV.US)2026年迎三大催化剂，目标价看高至 24 美元","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ROIV"],"gpt_icon":0},{"id":"1104547270","title":"Roivant強調持續的管線進展及公司下一階段增長的展望——2025投資者日","url":"https://stock-news.laohu8.com/highlight/detail?id=1104547270","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104547270?lang=zh_tw&edition=fundamental","pubTime":"2025-12-11 20:39","pubTimestamp":1765456740,"startTime":"0","endTime":"0","summary":"Roivant强调持续的管线进展及公司下一阶段增长的展望——2025投资者日","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV","BK4007","BK4139"],"gpt_icon":0},{"id":"1185595231","title":"Roivant Sciences：Lnp訴訟持續推進，法院於2025年9月在Pfizer/BioNTech案件中作出有利的Markman裁決","url":"https://stock-news.laohu8.com/highlight/detail?id=1185595231","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185595231?lang=zh_tw&edition=fundamental","pubTime":"2025-11-10 20:16","pubTimestamp":1762777002,"startTime":"0","endTime":"0","summary":"Roivant Sciences：Lnp诉讼持续推进，法院于2025年9月在Pfizer/BioNTech案件中作出有利的Markman裁决","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","ROIV"],"gpt_icon":0},{"id":"1142073891","title":"Roivant將在11月10日（星期一）發布2025年9月30日結束的第二季度財務業績及業務更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1142073891","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142073891?lang=zh_tw&edition=fundamental","pubTime":"2025-10-28 04:11","pubTimestamp":1761595872,"startTime":"0","endTime":"0","summary":"Roivant将在11月10日（星期一）发布2025年9月30日结束的第二季度财务业绩及业务更新。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","ROIV"],"gpt_icon":0},{"id":"2569173897","title":"拉馬斯瓦米支持的 Strive 公司將以 13 億美元收購塞姆勒公司，全股票交易，增加比特幣持有量","url":"https://stock-news.laohu8.com/highlight/detail?id=2569173897","media":"路透中文","labels":["shareholding","corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569173897?lang=zh_tw&edition=fundamental","pubTime":"2025-09-22 22:16","pubTimestamp":1758550597,"startTime":"0","endTime":"0","summary":"拉马斯瓦米支持的 Strive 公司将以 13 亿美元收购塞姆勒公司，全股票交易，增加比特币持有量路透社9月22日 - Strive >周一表示，它将以全股票交易的方式收购Semler Scientific SMLR.O，交易价值约为13.4亿美元，这家由美国前共和党总统候选人维韦克-拉马斯瓦米支持的比特币清算公司将扩大其持有的加密货币。Strive 还表示，它将以 6.75 亿美元的总价购买 5816 枚比特币。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"950086bf2c56d4fc088857661b3eb97e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250922:nL3S3V912M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STRK","BK4023","ROIV","ASST","BK4585","BK4516","BK4600","BK4009","BK4139","BK4595","BK4596","BK4007","BK4082","BK4588","SMLR"],"gpt_icon":1},{"id":"1123131695","title":"美股異動｜生物製藥公司Roivant升逾13%，Brepocitinib三期試驗數據表現積極","url":"https://stock-news.laohu8.com/highlight/detail?id=1123131695","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123131695?lang=zh_tw&edition=fundamental","pubTime":"2025-09-17 22:15","pubTimestamp":1758118526,"startTime":"0","endTime":"0","summary":"9月17日，生物制药公司$Roivant Sciences(ROIV)$涨超13%，宣布Brepocitinib药物三期研究数据积极。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"bf1f9917e89d16c929d49ce909869251","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","ROIV"],"gpt_icon":0},{"id":"1110459212","title":"Roivant Sciences Ltd.和Priovant宣佈Brepocitinib治療皮肌炎的3期Valor研究在52周安慰劑對照試驗中獲得積極結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1110459212","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110459212?lang=zh_tw&edition=fundamental","pubTime":"2025-09-17 19:02","pubTimestamp":1758106922,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd.和Priovant宣布Brepocitinib治疗皮肌炎的3期Valor研究在52周安慰剂对照试验中获得积极结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ROIV","BK4007"],"gpt_icon":0},{"id":"2566591155","title":"Roivant Sciences Ltd.盤中異動 臨近收盤急速拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566591155","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566591155?lang=zh_tw&edition=fundamental","pubTime":"2025-09-12 03:36","pubTimestamp":1757619374,"startTime":"0","endTime":"0","summary":"北京时间2025年09月12日03时36分，Roivant Sciences Ltd.股票出现异动，股价快速拉升5.01%。截至发稿，该股报14.46美元/股，成交量1017.08万股，换手率1.49%，振幅4.61%。Roivant Sciences Ltd.股票所在的生物技术行业中，整体涨幅为1.19%。Roivant Sciences Ltd.公司简介：Roivant Sciences Ltd是一家处于商业阶段的生物制药公司，致力于改善向患者提供医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250912033614a71c8b19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250912033614a71c8b19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","ROIV"],"gpt_icon":0},{"id":"1154255704","title":"Pulmovant旗下藥物Mosliciguat獲得日本孤兒藥認定，用於治療間質性肺病相關肺動脈高壓","url":"https://stock-news.laohu8.com/highlight/detail?id=1154255704","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154255704?lang=zh_tw&edition=fundamental","pubTime":"2025-09-04 19:00","pubTimestamp":1756983631,"startTime":"0","endTime":"0","summary":"Pulmovant宣布，其药物Mosliciguat已获得日本监管部门颁发的孤儿药认定，该药物用于治疗间质性肺病相关肺动脉高压（Ph-Ild）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","ROIV"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}]}}